Literature DB >> 20057284

Proteomics-based approach identified differentially expressed proteins with potential roles in endometrial carcinoma.

Zhengyu Li1, Wenjiao Min, Canhua Huang, Shujun Bai, Minghai Tang, Xia Zhao.   

Abstract

INSTRUCTION: We used proteomic approaches to identify altered expressed proteins in endometrial carcinoma, with the aim of discovering potential biomarkers or therapeutic targets for endometrial carcinoma.
METHODS: The global proteins extracted from endometrial carcinoma and normal endometrial tissues were separated by 2-dimensional electrophoresis and analyzed with PDQuest (Bio-Rad, Hercules, Calif) software. The differentially expressed spots were identified by mass spectrometry and searched against NCBInr protein database. Those proteins with potential roles were confirmed by Western blotting and immunohistochemical assays.
RESULTS: Ninety-nine proteins were identified by mass spectrometry, and a cluster diagram analysis indicated that these proteins were involved in metabolism, cell transformation, protein folding, translation and modification, proliferation and apoptosis, signal transduction, cytoskeleton, and so on. In confirmatory immunoblotting and immunohistochemical analyses, overexpressions of epidermal fatty acid-binding protein, calcyphosine, and cyclophilin A were also observed in endometrial carcinoma tissues, which were consistent with the proteomic results.
CONCLUSIONS: Our results suggested that these identified proteins, including epidermal fatty acid-binding protein, calcyphosine, and cyclophilin A, might be of potential values in the studies of endometrial carcinogenesis or investigations of diagnostic biomarkers or treatment targets for endometrial carcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20057284     DOI: 10.1111/IGC.0b013e3181a9026d

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  10 in total

1.  miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin.

Authors:  Quhui Wang; Lirong Zhu; Yasu Jiang; Junfei Xu; Feiran Wang; Zhixian He
Journal:  Oncol Lett       Date:  2017-01-04       Impact factor: 2.967

2.  Overexpression of calcyphosine is associated with poor prognosis in esophageal squamous cell carcinoma.

Authors:  Feng Li; Dengyan Zhu; Yang Yang; Kai Wu; Song Zhao
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967

3.  Altered protein expression in serum from endometrial hyperplasia and carcinoma patients.

Authors:  Yi-sheng Wang; Rui Cao; Hong Jin; Yi-ping Huang; Xiao-yan Zhang; Qing Cong; Yi-feng He; Cong-jian Xu
Journal:  J Hematol Oncol       Date:  2011-04-14       Impact factor: 17.388

4.  Identification of novel molecular targets for endometrial cancer using a drill-down LC-MS/MS approach with iTRAQ.

Authors:  Sébastien N Voisin; Olga Krakovska; Ajay Matta; Leroi V DeSouza; Alexander D Romaschin; Terence J Colgan; K W Michael Siu
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

5.  Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.

Authors:  Kazimierz O Wrzeszczynski; Vinay Varadan; James Byrnes; Elena Lum; Sitharthan Kamalakaran; Douglas A Levine; Nevenka Dimitrova; Michael Q Zhang; Robert Lucito
Journal:  PLoS One       Date:  2011-12-08       Impact factor: 3.240

6.  A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer.

Authors:  Stefan Enroth; Malin Berggrund; Karin Sundfeldt; Ulf Gyllensten; Maria Lycke; Martin Lundberg; Erika Assarsson; Matts Olovsson; Karin Stålberg
Journal:  Clin Proteomics       Date:  2018-12-01       Impact factor: 3.988

7.  Calcyphosine promotes the proliferation of glioma cells and serves as a potential therapeutic target.

Authors:  Zheng Zhu; Jiao Wang; Juan Tan; Yue-Liang Yao; Zhi-Cheng He; Xiao-Qing Xie; Ze-Xuan Yan; Wen-Juan Fu; Qing Liu; Yan-Xia Wang; Tao Luo; Xiu-Wu Bian
Journal:  J Pathol       Date:  2021-09-06       Impact factor: 9.883

8.  Abnormal expression of calcyphosine is associated with poor prognosis and cell biology function in colorectal cancer.

Authors:  Weiwei Shao; Quhui Wang; Feiran Wang; Yasu Jiang; Meirong Xu; Junfei Xu
Journal:  Onco Targets Ther       Date:  2016-01-25       Impact factor: 4.147

Review 9.  Proteomic Biomarkers for the Detection of Endometrial Cancer.

Authors:  Kelechi Njoku; Davide Chiasserini; Anthony D Whetton; Emma J Crosbie
Journal:  Cancers (Basel)       Date:  2019-10-16       Impact factor: 6.639

10.  Comprehensive Library Generation for Identification and Quantification of Endometrial Cancer Protein Biomarkers in Cervico-Vaginal Fluid.

Authors:  Kelechi Njoku; Davide Chiasserini; Bethany Geary; Andrew Pierce; Eleanor R Jones; Anthony D Whetton; Emma J Crosbie
Journal:  Cancers (Basel)       Date:  2021-07-28       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.